Effect of sofosbuvir-based hepatitis C virus therapy on kidney function in patients with CKD
Clinical Journal of the American Society of Nephrology Sep 11, 2017
Sise ME, et al. Â The safety and efficacy of sofosbuvir in patients with chronic kidney disease (CKD) were explored. In a cohort of patients with CKD infected with hepatitis C, results highlighted safety and effectivity of recommended regimen.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
